CompletedNCT06267846
A Study to Evaluate the Efficacy and Safety of NBI-1070770 in Adults With Major Depressive Disorder
Researchers compared NBI-1070770 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Medication studyAges 18–65United States
Understand this study
What did researchers investigate?
Researchers compared NBI-1070770 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
- Listed locations
- Little Rock and 12 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateStarted: March 20, 2024
- Recruitment status
- Completed
- Enrollment listed in the registry
- 73
- Sponsor
- Neurocrine Biosciences
- Sponsor type
- Biotech company
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06267846
- Official title
Show the full official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy, Safety, and Tolerability of NBI-1070770 in Adults With Major Depressive Disorder
Get this study by email
Recruitment & locations
CompletedLittle Rock · Rogers · Lemon Grove
10 more locations
- Long Beach
- Hollywood
- Maitland
- Decatur
- Savannah
- Gaithersburg
- Dayton
- North Canton
- Houston
- Richardson
Questions about this study
What did researchers investigate?
Researchers compared NBI-1070770 and placebo to find out how the approaches affected depression symptoms in adults with depression.
Who is behind this study?
The study sponsor is Neurocrine Biosciences, a biotech company.
Did this study involve medication?
Yes. The study involved medication, including NBI-1070770 and Placebo.
Who was this study for?
This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.
